Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (46)

2024

  1. Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations

    Cancers, Vol. 16, Núm. 15

2023

  1. Appendiceal Mucinous Neoplasms: From Clinic to Pathology and Prognosis

    Cancers, Vol. 15, Núm. 13

  2. External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification

    European Journal of Surgical Oncology, Vol. 49, Núm. 8, pp. 1481-1488

  3. Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

    Clinical and Translational Oncology, Vol. 25, Núm. 12, pp. 3378-3394

  4. Which classification system defines best prognosis of mucinous neoplasms of the appendix with peritoneal dissemination: TNM vs PSOGI?

    Journal of clinical pathology, Vol. 76, Núm. 4, pp. 266-273

2022

  1. ASO Author Reflections: Predicting Prognosis in Patients with Pseudomyxoma

    Annals of Surgical Oncology

  2. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

    BMC Cancer, Vol. 22, Núm. 1

  3. Multimodal approach of leiomyosarcoma of the inferior vena cava: case report and literature review of main points of controversy

    Chirurgia (Turin), Vol. 35, Núm. 5, pp. 291-298

  4. Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC

    Annals of Surgical Oncology, Vol. 29, Núm. 12, pp. 7553-7563

2021

  1. Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review

    BJS open, Vol. 5, Núm. 4

  2. Effect of cilastatin on cisplatin-induced nephrotoxicity in patients undergoing hyperthermic intraperitoneal chemotherapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-17

2020

  1. ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer

    Clinical and Translational Radiation Oncology, Vol. 24, pp. 41-48

  2. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

    Clinical and Translational Oncology, Vol. 22, Núm. 1, pp. 130-136

2018

  1. Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey

    European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236

  2. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups

    European Journal of Surgical Oncology, Vol. 44, Núm. 9, pp. 1378-1383

  3. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study

    European Journal of Surgical Oncology, Vol. 44, Núm. 11, pp. 1786-1792

2017

  1. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1388-1392

2016

  1. Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study

    Surgical Oncology, Vol. 25, Núm. 2, pp. 111-116

2015

  1. Intraoperative electron-beam radiation therapy with or without external-beam radiotherapy in the management of paraaortic lymph-node oligometastases from gynecological malignancies

    Clinical and Translational Oncology, Vol. 17, Núm. 11, pp. 910-916

  2. Single-Institution Multidisciplinary Management of Locoregional Oligo-Recurrent Pelvic Malignancies: Long-Term Outcome Analysis

    Annals of Surgical Oncology, Vol. 22, pp. 1247-1255